Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Каталог · ЕАЭС

Клинические исследования и проекты

Hoffmann-La Roche · найдено 111

Hoffmann-La Roche
Ищем по всем вариантам написания в реестрах, по-русски и по-английски. Спонсор или разработчик.
Статус
Что исследуют
Источник
Фаза
Страна
Участники
Кто может участвовать По критериям ClinicalTrials.gov. Исследования, где реестр возраст и пол не указывает, тоже показываются. Возраст и пол нигде не сохраняются.
Сбросить
111 исследований
Завершено Фаза III Беларусь
Interferon beta-1a; Ocrelizumab-matching placebo; Ocrelizumab; Interferon beta-1a-matching placebo · Hoffmann-La Roche

A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis

Минск, Витебск, Гродно 4 центра 835 участников во всех странах ClinicalTrials.gov WA21093
Завершено Фаза IV Казахстан
tocilizumab [RoActemra/Actemra] · Hoffmann-La Roche

Non-Randomized Phase IV Trial on Efficacy and Safety of Actemra in the Treatment of Adult Patients With Rheumatoid Arthritis

23 участника во всех странах ClinicalTrials.gov ML23037
Завершено Фаза III Казахстан
Vamikibart · Hoffmann-La Roche

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Алматы 1 центр 256 участников во всех странах ClinicalTrials.gov GR44278
Завершено Фаза III Казахстан
Trastuzumab; Paclitaxel; Docetaxel · Hoffmann-La Roche

An Open-Label, Randomized, Cross-Over, Multicenter, Phase IIIb Study, to Assess Patients' Tolerability of Trastuzumab Administrated Subcutaneously (SC) Either Via a Single Use Injection Device (SID) or Via Vial for Manual Administration (SC Vial) in Patients With HER2-Positive Early Breast Cancer (eBC)

Алматы, Астана 3 центра 90 участников во всех странах ClinicalTrials.gov ML28839
Идёт Фаза III Казахстан
Alectnib; Cisplatin; Vinorelbine; Gemcitabine; Pemetrexed; Carboplatin · Hoffmann-La Roche

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With Completely Resected Stage IB (Tumors Equal to or Larger Than 4cm) to Stage IIIA Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer

Алматы 1 центр 257 участников во всех странах ClinicalTrials.gov BO40336
Завершено Фаза III Казахстан
Atezolizumab; Placebo; Gemcitabine; Capecitabine; Carboplatin · Hoffmann-La Roche

A Phase III, Randomised, Double-Blind, Placebo-Controlled, Multicentre Study Of The Efficacy And Safety Of Atezolizumab Plus Chemotherapy For Patients With Early Relapsing Recurrent (Inoperable Locally Advanced Or Metastatic) Triple-Negative Breast Cancer

Алматы 1 центр 595 участников во всех странах ClinicalTrials.gov MO39193
Завершено Фаза III Казахстан
5-Fluorouracil; Capecitabine; Cisplatin; Pertuzumab; Placebo; Trastuzumab · Hoffmann-La Roche

A Double-Blind, Placebo-Controlled, Randomized, Multicenter Phase III Study Evaluating the Efficacy and Safety of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Metastatic Gastroesophageal Junction and Gastric Cancer

Алматы 1 центр 780 участников во всех странах ClinicalTrials.gov BO25114
Завершено Фаза II Россия
Actos; Placebo; aleglitazar · Hoffmann-La Roche

A Randomized, Double-blind Study to Investigate the Effect of Aleglitazar on Glycemic Control in Patients With Type 2 Diabetes Mellitus.

332 участника во всех странах ClinicalTrials.gov BM17864
Завершено Фаза II Россия
Actos; aleglitazar · Hoffmann-La Roche

A Randomized, Double Blind Study to Compare the Safety and Tolerability of Aleglitazar and Actos in Patients With Type 2 Diabetes and NYHA Class II Heart Failure.

14 участников во всех странах ClinicalTrials.gov BC20265
Завершено Фаза III Россия
Tocilizumab; Placebo to tocilizumab; Methotrexate; Placebo to methotrexate · Hoffmann-La Roche

A Multi-center, Randomized, Double-blind, Parallel Group Study of the Safety, Disease Remission and Prevention of Structural Joint Damage During Treatment With Tocilizumab (TCZ), as a Monotherapy and in Combination With Methotrexate (MTX), Versus Methotrexate in Patients With Early, Moderate to Severe Rheumatoid Arthritis

Москва, Санкт-Петербург и ещё 6 городов 12 центров 1 162 участника во всех странах ClinicalTrials.gov WA19926
Завершено Россия
BV28333 · Hoffmann-La Roche

An Exploratory Evaluation of Interleukin 28B (IL28B) Genotype, Single Nucleotide Polymorphisms (SNP) of rs12356193, Protein and RNA Biomarkers in Serum Samples (Stored, Already Obtained From Completed Studies) From Subjects With HBe-antigen Positive or Negative Chronic Hepatitis B, Who Have Completed Therapy for Hepatitis B With Pegasys ± Lamivudine.

269 участников во всех странах ClinicalTrials.gov BV28333
Завершено Фаза III Россия
Herceptin · Hoffmann-La Roche

A Single Arm, Multi-Center, International, Continuation Trial of Recombinant Humanized Antibody Herceptin (Trastuzumab) in Patients With HER2-Overexpressing Tumors

69 участников во всех странах ClinicalTrials.gov BO15943
Завершено Фаза IV Россия
Methotrexate; rituximab [MabThera/Rituxan] · Hoffmann-La Roche

An Open Label Study to Evaluate the Safety and Effect on Treatment Response of MabThera in Patients With Rheumatoid Arthritis Following Inadequate Response to One Prior Anti-TNF Inhibitor

60 участников во всех странах ClinicalTrials.gov ML21271
Завершено Фаза IV Россия
peginterferon alfa-2a [Pegasys] · Hoffmann-La Roche

PEGASYS® (Peginterferon Alpha-2a 40KD) in Patients With HBeAg-positive and HBeAg-negative Chronic Hepatitis B

18 участников во всех странах ClinicalTrials.gov ML20003
Завершено Фаза II Россия
pertuzumab; paclitaxel; gemcitabine; carboplatin · Hoffmann-La Roche

A Randomized, Open-label Study of the Effect of Omnitarg in Combination With Carboplatin-based Chemotherapy Versus Carboplatin-based Therapy Alone on Treatment Response in Patients With Platinum-sensitive Recurrent Ovarian Cancer

149 участников во всех странах ClinicalTrials.gov BO17931
Завершено Фаза III Россия
methoxy polyethylene glycol-epoetin beta [C.E.R.A.] · Hoffmann-La Roche

A Single Arm Open Label Multicentre Study to Assess the Efficacy, Safety and Tolerability of Monthly Administration of Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anaemia in Pre-dialysis Patients, Not Currently Treated With ESA

133 участника во всех странах ClinicalTrials.gov ML20978
Завершено Фаза IV Россия
peginterferon alfa-2a [Pegasys] · Hoffmann-La Roche

Multicenter Open-label Observation Program in Patients With Chronic Hepatitis C and With Chronic Renal Failure (CRF) Receiving Peginterferon Alpha-2a (40 kDa) Pegasys

27 участников во всех странах ClinicalTrials.gov ML20434
Завершено Фаза III Россия
insulin glargine; metformin; taspoglutide; taspoglutide · Hoffmann-La Roche

A Multicenter, Randomized, Open-label, Active-controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin-naïve Type 2 Diabetic Patients Inadequately Controlled With Metformin and Sulphonylurea Combination Therapy

1 072 участника во всех странах ClinicalTrials.gov BC20965
Завершено Фаза IV Россия
peginterferon alfa-2a [Pegasys]; ribavirin · Hoffmann-La Roche

Safety and Tolerability of Ribavirin (RO 20-9963) in Combination With Peginterferon Alfa-2a (40 kD)in Patients With Chronic Hepatitis C

6 661 участник во всех странах ClinicalTrials.gov ML16709

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.